Covered recipient · General Payments record
KIDEST MEZGEBE GEBREAMANUEL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2023–2024
$664.91
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $476.90 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $222.56 | 14 |
| PFIZER INC. | $38.99 | 2 |
| Neurocrine BioSciences, Inc. | $38.85 | 1 |
| Otsuka America Pharmaceutical, Inc. | $37.57 | 2 |
| Aucta Pharmaceuticals, Inc. | $24.62 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $24.29 | 1 |
| Janssen Pharmaceuticals, Inc | $23.20 | 1 |
| Avadel CNS Pharmaceuticals, LLC | $22.60 | 1 |
| EMD Serono, Inc. | $22.25 | 1 |
| Biogen, Inc. | $21.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.26 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107159699 | CMS |
| ABBVIE INC. | $33.52 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107159701 | CMS |
| ABBVIE INC. | $4.78 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107159703 | CMS |
| ABBVIE INC. | $9.78 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107159705 | CMS |
| ABBVIE INC. | $14.91 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107159707 | CMS |
| ABBVIE INC. | $9.80 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107159709 | CMS |
| ABBVIE INC. | $9.49 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107159711 | CMS |
| ABBVIE INC. | $12.56 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107159713 | CMS |
| ABBVIE INC. | $24.02 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107159715 | CMS |
| ABBVIE INC. | $8.99 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107159717 | CMS |
| ABBVIE INC. | $12.06 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107159719 | CMS |
| ABBVIE INC. | $21.05 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107159721 | CMS |
| ABBVIE INC. | $7.10 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107159723 | CMS |
| ABBVIE INC. | $22.24 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107159725 | CMS |
| Aucta Pharmaceuticals, Inc. | $24.62 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147905292 | CMS |
| Avadel CNS Pharmaceuticals, LLC | $22.60 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123391994 | CMS |
| Biogen, Inc. | $21.97 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104858114 | CMS |
| EMD Serono, Inc. | $22.25 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120245295 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $24.29 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146772074 | CMS |
| Janssen Pharmaceuticals, Inc | $23.20 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078191729 | CMS |
| Neurocrine Biosciences, Inc. | $38.85 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150929041 | CMS |
| Otsuka America Pharmaceutical, Inc. | $13.60 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119078190 | CMS |
| Otsuka America Pharmaceutical, Inc. | $23.97 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119078192 | CMS |
| PFIZER INC. | $20.40 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131806935 | CMS |
| PFIZER INC. | $18.59 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131821200 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.